The American Heart Association just coined the term a few years ago.

BODi (NASDAQ: BODI), formerly known as Beachbody, today launched P90X Generation Next, the newest installment of P90X, which ...

FDA priority review seeks marstacimab label expansion to ≥6 years with inhibitors and ages 6–11 without inhibitors, addressing populations with limited efficacy from factor replacement and high unmet ...

Eli Lilly’s Zepbound is still viewed as the leading weight-loss shot, according to a ...

Sustained interest in small molecules, bispecific antibodies, and genomics got the ball rolling in the biotech deals arena in ...

From rare cancers caught early to dementia foretold decades in advance, newborn genomic testing raises an unsettling question ...

Discover how Electroencephalography (EEG) records brain activity to diagnose epilepsy, strokes, and sleep disorders. Learn ...

Altimmune, Inc. closed a $75 million direct offering to fund Phase 3 pemvidutide trials for MASH. Learn more about ALT stock ...

Results from a recently published randomized, double-blind, placebo-controlled clinical trial show that supplementation with Brightseed® BioMetaControl, containing the naturally occurring bioactive ...

Achieve Life Sciences is a single-asset microcap centered on cytisinicline, with an accepted NDA and a June 20, 2026, PDUFA.

AT HIS NOMINATION hearing in January 2025, Robert F. Kennedy Jr. announced he’d “do everything in my power to put the health ...